|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02427 GUANZE MEDICAL
Nominal 
0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 8.612% | 6.749% | 12.815% | 20.046% | 16.429% |
| ROAE (%) | 10.412% | 8.494% | 17.586% | 33.627% | 30.047% |
| Return on Capital Employed (%) | 10.183% | 6.882% | 14.095% | 28.403% | 30.047% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 54.722% | 45.720% | 35.863% | 33.386% | 32.959% |
| EBITDA Margin (%) | 28.625% | 20.468% | 18.018% | 23.342% | 22.459% |
| Pre-tax Profit Margin (%) | 24.764% | 16.917% | 15.661% | 21.147% | 21.015% |
| Net Profit Margin (%) | 17.663% | 10.131% | 10.866% | 15.747% | 15.852% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 6.514 X | 4.375 X | 4.197 X | 2.438 X | 1.949 X |
| Quick Ratio (X) | 6.254 X | 4.145 X | 3.893 X | 2.019 X | 1.393 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 13.496% | 20.469% | 20.334% | 36.030% | 45.323% |
| Total Debt / Total Assets (%) | 6.991% | 7.836% | 7.459% | 5.590% | 0.759% |
| Net Debt / Total Assets (%) | -14.882% | -1.125% | -2.458% | 2.002% | -4.020% |
| Total Debt / Shareholders' Funds (%) | 8.109% | 9.872% | 9.372% | 8.738% | 1.389% |
| Long Term Debt / Shareholders' Funds (%) | 0.146% | 0.037% | 0.095% | 3.872% | 0% |
| Net Debt / Shareholders' Funds (%) | -17.262% | -1.417% | -3.088% | 3.130% | -7.352% |
| Net Cash / (Debt) ($) | 46.505M | 3.687M | 5.015M | (3.081M) | 5.462M |
| Net Cash / (Debt) per share ($) | 0.049 | 0.004 | -- | -- | -- |
| Total Debt / Capital Employed (%) | 8.070% | 9.849% | 9.354% | 8.413% | 1.389% |
| Interest Coverage Ratio (X) | 45.890 X | 30.061 X | 56.372 X | 50.433 X | 581.294 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 67.910 Day | 53.108 Day | 46.109 Day | 82.981 Day | 132.341 Day |
| Receivables Turnover (Day) | 321.714 Day | 301.089 Day | 202.216 Day | 164.753 Day | 181.094 Day |
| Payables Turnover (Day) | 4.290 Day | 17.622 Day | 15.207 Day | 2.906 Day | 0.415 Day |
| Remarks: | Real time quote last updated: 25/11/2024 07:37 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -160,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.000 |
| NBV Per Share (¥) | RMB 0.254 |